Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers
Pharmaceuticals · 11.07.2024 · 17 (7) · 932
DOI: 10.3390/ph17070932 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 11.07.2024. Verfasst von David Aebisher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Photomedicine and Physical Chemistry, Medical College of the University of Rzeszów, 35-959 Rzeszów, Poland. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a promising cancer treatment method that uses photosensitizing (PS) compounds to selectively destroy tumor cells using laser light. This review discusses the main advantages of PDT, such as its low invasiveness, minimal systemic toxicity and low risk of complications. Special attention is paid to photosensitizers obtained by chemical synthesis. Three generations of photosensitizers are presented, starting with the first, based on porphyrins, through the second generation, including modified porphyrins, chlorins, 5-aminolevulinic acid (ALA) and its derivative hexyl aminolevulinate (HAL), to the third generation, which is based on the use of nanotechnology to increase the selectivity of therapy. In addition, current research trends are highlighted, including the search for new photosensitizers that can overcome the limitations of existing therapies, such as heavy-atom-free nonporphyrinoid photosensitizers, antibody–drug conjugates (ADCs) or photosensitizers with a near-infrared (NIR) absorption peak. Finally, the prospects for the development of PDTs are presented, taking into account advances in nanotechnology and biomedical engineering. The references include both older and newer works. In many cases, when writing about a given group of first- or second-generation photosensitizers, older publications are used because the properties of the compounds described therein have not changed over the years. Moreover, older articles provide information that serves as an introduction to a given group of drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Photomedicine and Physical Chemistry, Medical College of the University of Rzeszów, 35-959 Rzeszów, Poland.
- Students English Division Science Club, Medical College of the University of Rzeszów, 35-959 Rzeszów, Poland.
- Department of Internal Medicine, Health Care, 39-100 Ropczyce, Poland.
- Center for Innovative Research in Medical and Natural Sciences, Medical College of the University of Rzeszów, 35-310 Rzeszów, Poland.
- Department of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8 Str., 41-200 Sosnowiec, Poland.
- Center for Laser Diagnostics and Therapy, Department of Internal Medicine, Angiology and Physical Medicine, Medical University of Silesia in Katowice, Batorego 15 Street, 41-902 Bytom, Poland.
ORCID-Profile: David Aebisher, Klaudia Dynarowicz, Ewa Chodurek, Dorota Bartusik-Aebisher
Zitieren
APA
Aebisher, D., Serafin, I., Batóg-Szczęch, K., Dynarowicz, K., Chodurek, E., Kawczyk-Krupka, A., & Bartusik-Aebisher, D. (2024). Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers. Pharmaceuticals, 17(7), 932. https://doi.org/10.3390/ph17070932
Vancouver
Aebisher D, Serafin I, Batóg-Szczęch K, Dynarowicz K, Chodurek E, Kawczyk-Krupka A, et al. Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers. Pharmaceuticals. 2024;17(7):932. doi:10.3390/ph17070932
BibTeX
@article{Aebisher2024,
author = {Aebisher, David and Serafin, Iga and Batóg-Szczęch, Katarzyna and Dynarowicz, Klaudia and Chodurek, Ewa and Kawczyk-Krupka, Aleksandra and Bartusik-Aebisher, Dorota},
title = {Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {7},
pages = {932},
doi = {10.3390/ph17070932}
}
EUVIMED